Sera Prognostics Joins ARPA-H Program to Develop Point of Care Birth Diagnostic

June 25, 2026
Sera Prognostics is collaborating with UC San Diego and Allegro MicroSystems on an ARPA-H funded project to create a point of care diagnostic test for fetal oxygen levels during labor.

Sera Prognostics has joined a research collaboration led by University of California San Diego and Allegro MicroSystems, supported by up to 10.4 million dollars from ARPA-H. The goal is to create a point of care diagnostic test that improves safety during labor and delivery, announced in a press release.

The project is part of ARPA-H's Making Obstetrics Care Smart program and focuses on developing a diagnostic tool that can evaluate the risk of low fetal oxygen levels, or fetal hypoxia, using a small maternal blood sample. The test aims to provide clinicians with timely and objective data to support intervention decisions.

Sera Prognostics will contribute its expertise in protein biomarker discovery and validation to identify biomarker signatures linked to placental dysfunction, fetal stress, or hypoxia risk. The research team plans to integrate these biomarkers into a rapid testing platform designed for use during childbirth.

The collaboration seeks to advance maternal and neonatal care by enabling more precise, data supported decision making during labor.

We hope you enjoyed this article.

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more